Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H-X.
Right arrow Articles by Fratiglioni, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H-X.
Right arrow Articles by Fratiglioni, L.
Neurology 2001;56:1188-1194
© 2001 American Academy of Neurology
Articles

Vitamin B12 and folate in relation to the development of Alzheimer’s disease

H-X. Wang, BA;, Å. Wahlin, PhD;, H. Basun, MD, PhD;, J. Fastbom, MD, PhD;, B. Winblad, MD, PhD; and L. Fratiglioni, MD, PhD

From the Stockholm Gerontology Research Center and Division of Geriatric Medicine (Drs. Wang, Wahlin, Basun, Fastbom, Winblad, and Fratiglioni), NEUROTEC, Karolinska Institutet, Stockholm; and Astra Zeneca (Dr. Basun), Clinical Science, R & D Södertälje, Sweden.

Address correspondence and reprint requests to Dr. Hui-Xin Wang, Stockholm Gerontology Research Center, Box 6401, S-113 82 Stockholm, Sweden; e-mail: Huixin.wang{at}phs.ki.se

OBJECTIVE: To explore the associations of low serum levels of vitamin B12 and folate with AD occurrence.

METHODS: A population-based longitudinal study in Sweden, the Kungsholmen Project. A random sample of 370 nondemented persons, aged 75 years and older and not treated with B12 and folate, was followed for 3 years to detect incident AD cases. Two cut-off points were used to define low levels of vitamin B12 (<=150 and <=250 pmol/L) and folate (<=10 and <=12 nmol/L), and all analyses were performed using both definitions. AD and other types of dementia were diagnosed by specialists according to DSM-III-R criteria.

RESULTS: When using B12 <=150pmol/L and folate <=10 nmol/L to define low levels, compared with people with normal levels of both vitamins, subjects with low levels of B12 or folate had twice higher risks of developing AD (relative risk [RR] = 2.1, 95% CI = 1.2 to 3.5). These associations were even stronger in subjects with good baseline cognition (RR = 3.1, 95% CI = 1.1 to 8.4). Similar relative risks of AD were found in subjects with low levels of B12 or folate and among those with both vitamins at low levels. A comparable pattern was detected when low vitamin levels were defined as B12 <=250 pmol/L and folate <=12 nmol/L.

CONCLUSIONS: This study suggests that vitamin B12 and folate may be involved in the development of AD. A clear association was detected only when both vitamins were taken into account, especially among the cognitively intact subjects. No interaction was found between the two vitamins. Monitoring serum B12 and folate concentration in the elderly may be relevant for prevention of AD.




This article has been cited by other articles:


Home page
 Epidemiol RevHome page
N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand
Dementia Prevention: Methodological Explanations for Inconsistent Results
Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. M. de Lau, H. Refsum, A D. Smith, C. Johnston, and M. M. Breteler
Plasma folate concentration and cognitive performance: Rotterdam Scan Study
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 728 - 734.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. Raman, A. Tatsioni, M. Chung, I. H. Rosenberg, J. Lau, A. H. Lichtenstein, and E. M. Balk
Heterogeneity and Lack of Good Quality Studies Limit Association Between Folate, Vitamins B-6 and B-12, and Cognitive Function
J. Nutr., July 1, 2007; 137(7): 1789 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. M. Balk, G. Raman, A. Tatsioni, M. Chung, J. Lau, and I. H. Rosenberg
Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function: A Systematic Review of Randomized Trials
Arch Intern Med, January 8, 2007; 167(1): 21 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. A. Luchsinger, M.-X. Tang, J. Miller, R. Green, and R. Mayeux
Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly
Arch Neurol, January 1, 2007; 64(1): 86 - 92.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
P. Thomas and M. Fenech
A review of genome mutation and Alzheimer's disease
Mutagenesis, January 1, 2007; 22(1): 15 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. Feng, T.-P. Ng, L. Chuah, M. Niti, and E.-H. Kua
Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1506 - 1512.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
M. Tettamanti, M. T. Garri, A. Nobili, E. Riva, and U. Lucca
Low Folate and the Risk of Cognitive and Functional Deficits in the Very Old: The Monzino 80-plus Study
J. Am. Coll. Nutr., December 1, 2006; 25(6): 502 - 508.
[Abstract] [Full Text] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
S. Annerbo, L.-O. Wahlund, and J. Lokk
The Significance of Thyroid-Stimulating Hormone and Homocysteine in the Development of Alzheimer's Disease in Mild Cognitive Impairment: A 6-Year Follow-up Study
American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 182 - 188.
[Abstract] [PDF]

Home page
 J Gerontol B Psychol Sci Soc SciHome page
D. Bunce, M. Kivipelto, and A. Wahlin
Apolipoprotein E, B Vitamins, and Cognitive Function in Older Adults
J Gerontol B Psychol Sci Soc Sci, January 1, 2005; 60(1): P41 - P48.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. M. Pfeiffer, Z. Fazili, L. McCoy, M. Zhang, and E. W. Gunter
Determination of Folate Vitamers in Human Serum by Stable-Isotope-Dilution Tandem Mass Spectrometry and Comparison with Radioassay and Microbiologic Assay
Clin. Chem., February 1, 2004; 50(2): 423 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al.
Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Clin. Chem., January 1, 2004; 50(1): 3 - 32.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
G. C. Rampersaud, G. P.A. Kauwell, and L. B. Bailey
Folate: A Key to Optimizing Health and Reducing Disease Risk in the Elderly
J. Am. Coll. Nutr., February 1, 2003; 22(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
T. Bottiglieri
S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule
Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1151S - 1157S.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta, and P. M. Rossini
Elevation of serum copper levels in Alzheimer's disease
Neurology, October 22, 2002; 59(8): 1153 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
E H Reynolds
Folic acid, ageing, depression, and dementia
BMJ, June 22, 2002; 324(7352): 1512 - 1515.
[Full Text] [PDF]

Home page
 NeurologyHome page
A. McCaddon, B. Regland, P. Hudson, and G. Davies
Functional vitamin B12 deficiency and Alzheimer disease
Neurology, May 14, 2002; 58(9): 1395 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A D. Smith
Homocysteine, B vitamins, and cognitive deficit in the elderly
Am. J. Clinical Nutrition, May 1, 2002; 75(5): 785 - 786.
[Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
E H Reynolds
Benefits and risks of folic acid to the nervous system
J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 567 - 571.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Seshadri, A. Beiser, J. Selhub, P. F. Jacques, I. H. Rosenberg, R. B. D'Agostino, P. W.F. Wilson, and P. A. Wolf
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
N. Engl. J. Med., February 14, 2002; 346(7): 476 - 483.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. R. M. Rieder, D. Fricke, H. X. Wang, A. Wahlin, H. Basun, J. Fastbom, B. Winblad, and L. Fratiglioni
Vitamin B12 and folate in relation to the development of Alzheimer's disease
Neurology, November 13, 2001; 57(9): 1742 - 1743.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Vitamin B12 and folate in relation to the development of Alzheimer’s disease
Carlos R M Rieder, et al.
Neurology Online, 26 Jun 2001 [Full text]
Reply to Carlos R M Rieder
Hui-Xin Wang
Neurology Online, 26 Jun 2001 [Full text]
Reply to Wang and Rieder
Sander Fridman
Neurology Online, 8 Jul 2001 [Full text]